HeartSciences Inc Warrant
HSCSW
3 hedge funds and large institutions have $23.2K invested in HeartSciences Inc Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
57.31% more ownership
Funds ownership: 0.83% → 58.15% (+57%)
7% more capital invested
Capital invested by funds: $21.8K → $23.2K (+$1.46K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$332 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$165 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$117 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$26 |
HSCSW Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q3 2024, worth a combined $23.2K — up 6.7% from $21.8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HSCSW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $332. The largest seller was Citadel Advisors, cutting an estimated $165.
- 3 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q3 2024, down from 5 in Q2 2024.
- Funds reported $23.2K of HeartSciences Inc Warrant stock for Q3 2024, up 6.7% quarter-over-quarter.
- 0 funds opened new HeartSciences Inc Warrant positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest HeartSciences Inc Warrant buyer in Q3 2024 was Susquehanna International Group, an estimated $332 added.
- The largest HeartSciences Inc Warrant seller in Q3 2024 was Citadel Advisors, an estimated $165 sold.
Based on aggregated 13F filings for Q3 2024.